A randomised, crossover, single-dose, phase I trial of three different formulations of controlled release CTP 499 in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 19 Oct 2011
At a glance
- Drugs CTP 499 (Primary)
- Indications Diabetic nephropathies
- Focus Adverse reactions
- 19 Oct 2011 Results were presented at the American Society of Nephrology's (ASN) Kidney Week 2011, according to a Concert Pharmaceuticals media release.
- 22 Jun 2011 New trial record